HLA-A*02:01 & B2M & NY-ESO-1 (SLLMWITQV)

HLA-A*02:01 & B2M & NY-ESO-1 (SLLMWITQV) Liste de produits

Attribut
Protein (2)
Bibliothèque de produits
En ligne (2)
Espèces
Human (2)
Étiquette
His Tag & Avi Tag (1)His Tag (1)
Marqueur
Biotin-labeled (1)Unconjugated (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
HOT HL1-H82E4	Human	HEK293	Biotinylated Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Complex Protein (Monomer, MALS & SPR verified)				Ajouter au panier
HL1-H52E7	Human	HEK293	Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein (MALS & SPR verified)				Ajouter au panier

Quantité totale2

HLA-A*02:01 & B2M & NY-ESO-1 (SLLMWITQV)Contexte de la molécule

NY-ESO-1, which is also well-known as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancer-testis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ovarian, cervical cancer, etc. Adoptive T cell therapy with HLA-A2 restricted NY-ESO-1 transduced CD8+ T cells has improved the clinical response rates and overall survival of treatment-refractory melanoma patients. The Human HLA-A*0201 NY-ESO-1 (SLLMWITQV) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M and SLLMWITQV peptide of the NY-ESO-1.